Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
Conclusions: MIF is an important player and a novel therapeutic target in MM. Inhibiting MIF activity will sensitize MM cells to chemotherapy.
Source: JNCI - Category: Cancer & Oncology Authors: Zheng, Y., Wang, Q., Li, T., Qian, J., Lu, Y., Li, Y., Bi, E., Reu, F., Qin, Y., Drazba, J., Hsi, E., Yang, J., Cai, Z., Yi, Q. Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Genetics | Myeloma | Statistics | Students | Universities & Medical Training